Cargando...
Narrative review: the holy grail: update on pharmacotherapy for heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction (HFpEF) is the presence of clinical signs and/or symptoms of heart failure with a left ventricular ejection fraction (LVEF) ≥50%. Risk factors associated with this disease include hypertension, hyperlipidemia, atrial fibrillation (AF), obesity, diabetes...
Guardado en:
| Publicado en: | Ann Transl Med |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
AME Publishing Company
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8039660/ https://ncbi.nlm.nih.gov/pubmed/33850920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-4602 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|